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A longitudinal, five year survey of urea kinetic parameters in CAPD
patients. This study reports on the five years' evolution of the KT/V
urea index and protein catabolic rate (PCR) in 16 CAPD patients who
were treated with a constant daily dialysis dose. Total KT/V urea index
decreased with time from a value of 0.96 0.06 at the start to 0.55
0.05 at five years of treatment. This dcclinc was due to the opposite
changes of two important parameters affecting the index. First, the
contribution of the residual urinary KT/V gradually decreased from
28.6% at the start to 8 to 9% after four years. Second, the distribution
volume of urea calculated as a constant fraction of body weight
gradually increased. The body weight increased from 58.2 2.79 kg at
start to 70.6 3,33 kg at five years. Peritoneal urea clearances and
ultrafiltration rates remained stable. In 12 patients with stable body
weight between 24 and 48 months, PCR decreased from 0.98 0.05 to
0.87 0.05 g/kg/day. A positive correlation between KT/V urea and
PCR and a negative correlation between KT/V urea and number of
hospitalization days, peritonitis rates and peripheral nerve conductivity
was found. The same negative correlation was found when only the
KT/V urea index obtained during the first year of treatment was
considered. In conclusion, the KT/V urea index decreases in CAPD
patients primarily because residual renal function decreases and body
weight increases, while the peritoneal clearing for urea is maintained.
The index correlates with some clinical parameters, and may have some
prognostic value.
Urea clearance normalized for distribution volume, termed
KT/V urea as an index of adequate solute removal in hemodi-
alysis, has led to the widespread introduction of urea kinetic
modeling in many hemodialysis centers.
Although the interpretation of the KT/V urea index has been
criticized [1], and the concept has been misapplied [2, 3}, it will
continue to be accepted as a simple, practical and unambiguous
index of adequate solute removal by dialysis.
Because urea is the predominant nitrogenous waste product
of protein catabolism, urea kinetics allow further the monitoring
of protein intake in dialyzed patients.
Urea kinetic modeling has only recently been introduced as
an index of dialysis adequacy for patients treated with contin-
uous ambulatory peritoneal dialysis (CAPD). In a cross sec-
tional analysis, Lysaght et al [4] calculated a mean normalized
KT/V urea index of 0.59 0.04 in a cohort of 30 CAPD patients
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(mean dialysis time 26 3.2 months) compared with a mean
KT/V urea index of 1.01 0.05 in a cohort of 35 hemodialysis
patients (mean dialysis time 36 6.2 months). After a survey of
the literature data on morbidity and mortality with both dialysis
techniques, the authors suggested that a KT/V urea value of
0.60 in CAPD appears to be broadly equivalent to an index of
1.0 in hemodialysis patients.
As far as we know, only two recent reports on the predictive
value of urea kinetic modeling by calculation of the KTIV urea
index and the protein catabolic rate (PCR) in CAPD patients
have been published [5, 6]. Teehan et alES] found that the KT/V
urea index was significantly higher in patients who remained
unhospitalized and were transfusion-independent, compared to
those who needed hospitalizations and who were transfusion-
dependent. It was concluded that urea kinetic parameters
affected some clinical outcome parameters in CAPD patients.
However, no evolution of the KT/V urea index in the same
patients was given. Blake et al [6] prospectively studied urea
kinetics in 76 new CAPD patients over a three year observation
period. Only 18 of the 76 patients completed the follow-up of
the three year study of urea kinetic parameters. Furthermore,
the prescribed dialysis regime was altered in 42 of the 76
patients during the study. It was noted that among the kinetic
parameters studied, KT/V urea index and protein catabolic
rates (PCR) decreased with time. This was mainly due to a
significant decrease in residual renal function. Most impor-
tantly, no correlation between urea kinetics and several para-
meters related to clinical outcome of the patients was found in
this study. The present study uses a different approach com-
pared to the two previous studies and examines five years of
evolution of the KT/V urea index and PCR calculation in a
cohort of the same patients. All patients completed the entire
five-year study period and were treated for the whole period
with CAPD in a fixed daily dialysis dose.
Since in this group of non-diabetic patients no patient or
technical dropout occurred and no therapeutic adjustments
according to urea kinetics or calculated PCRs were performed,
it permits an analysis of some parameters that are influenced by
the KT/V urea index over a long period of time without external
interference.
The results indicate that the KT/V urea index in CAPD was
decreasing over time by a combination of two factors: the
decline in residual renal function and the increase in body
weight, affecting the calculation of the urea distribution volume.
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The peritoneal urea and creatinine clearances remained con-
stant. In addition, the index obtained during the first year of
treatment was inversely correlated with overall morbidity and
incidence of peritonitis.
Methods
The 16 patients (4 males, 12 females) were selected from the
CAPD program at the University Hospital of Gent, the only
selection criterium being an uninterrupted CAPD therapy in an
individually constant dose for at least five years. During the
same period a total number of 126 patients started CAPD.
Therefore, these 16 patients represent 12.7% of our total
population, started on CAPD treatment over the same time
interval. The patients had either refused or presented with
various medical contraindications for kidney transplantation. In
the study cohort, the mean age at the start of CAPD therapy
was 55.5 years (range 35 to 70 years). The underlying renal
diseases were chronic pyelo-interstitial disease (N = 6), chronic
glomerular disease (N 5), nephro-angiosclerosis (N = 2),
congenital kidney disease (N = 2), and amyloidosis (N = 1).
All patients were dialyzed with DianealR (glucose solutions),
4 x 2 liter exchanges per day, except for one patient who used
4 x 3 liters per day. After training, every patient was regularly
seen at the outpatient department every two to three months. A
24-hour urine and dialysate collection was brought to the
outpatient department. At the consultation, a routine clinical
and biochemical check-up was performed, including measure-
ment of body weight, and blood pressure. Every year, periph-
eral motor nerve conduction velocity (mlsec) was measured in
the lateral peroneal nerve.
Calculations
The peritoneal urea clearance (mi/mm) was calculated every
six months by the formula DIP x V, where DIP is the dialysate
to plasma urea ratio, and V is the volume of the drained
dialysate over 24 hours.
To evaluate dialytic KT/V urea, the 24 hour clearances were
divided by the urea distribution volume. Net peritoneal ultrafil-
tration was determined as the mean of eight daily net ultrafil-
tration rates, as noted by the patient the week before consulta-
tion. These values were calculated as the weight difference
between the instilled and drained dialysate volumes. Urea
distribution volume was estimated according to two methods.
First, it was calculated as 60% and 55% of ideal body weight
(IBW) in males and females, respectively [6]. IBW was the
weight of the patient in the absence of signs or symptoms of
either volume depletion or hypervolemia. Alternatively, urea
distribution volume assumed to be equal to total body water
(V), was calculated according to Watson, Watson and Batt [7].
The Watson formulae for the calculation of total body water are
different in men and women:
In men: V = 2.447 — (0.09516 x a) + (0.1074 x L)
+ (0.3362 x BW)
In women: V = — 2.907 + (0.1069 X L)
+ (0.2466 x BW)
where a is age (years), L is length (cm) and BW is body weight
(kg).
According to previous papers [4, 6], the daily total urea
clearance was multiplied by 2.33 (= 7/3) to provide time
equivalence to the thrice weekly dialysis schedule of hemodi-
alysis patients.
In 12 patients where, between 24 and 48 months of treatment,
dry body weight remained stable and therefore metabolic
equilibrium was assumed, the generation rate for urea (G) was
calculated from the 24 hour quantity of urea present in the
peritoneal effluent and the urine.
Protein catabolic rates (PCR) were derived from the correla-
tion developed by Borah et al [8] for hemodialysis patients and
validated for CAPD patients by Randerson, Chapman and
Farrell [9],
PCR = (G + 1.7)10.154
where G refers to urea nitrogen appearance rate in dialysate and
urine. PCR and G are in units of g/24 hrs. The calculated PCR
was increased for the daily amount of protein lost via dialysate
and urine, and the value was then divided by body weight to
obtain PCR in g/kg body weight.
Start values for the dialysis parameters are the results ob-
tained after a stable CAPD regime was achieved. These values
were usually obtained at the end of the first two to three weeks
after CAPD was initiated and corresponded with the first
outpatient consultation.
In all 16 patients, correlations were sought between the mean
KT/V urea index and a number of clinical and biochemical
parameters. Among the clinical outcomes that were monitored
every year were hospitalization days, peritonitis rate, and
measurement of nerve conduction velocity (mlsec) in the lateral
peroneal nerve. Biochemical parameters that were followed
were serum creatinine, blood urea, serum electrolytes, alkaline
phosphatase, hematocrit and serum albumin every three
months, and serum parathyroid hormone levels, every six
months. The values were averaged for each year period. A
possible relation was evaluated between the individual overall
five-year KT/V urea indices and the peritonitis incidence and
hospitalization rates over the whole period of five years. The
same relation, using only the individual KT/V urea index over
the first year of treatment versus the same parameters, was also
studied.
In the 12 patients in whom PCR was calculated between 24
and 48 months of CAPD, a correlation between KT/V urea
index and PCR in this observation period was calculated. For
this analysis, 58 values of both parameters could be used.
All data are expressed as means standard errors of mean.
Statistical differences between means were compared by
Wilcoxon's test for paired and unpaired observations. Correla-
tions were calculated using Pearson's correlation coefficient. A
P value less than 0.05 was assumed to be significant.
Results
Table 1 summarizes the five year evolution of blood urea
(mg/dl), serum creatinine (mgldl), dry body weight (kg), perito-
neal urea clearances (mI/mm) and peritoneal ultrafiltration (UF)
rates (mllday) in the 16 patients.
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Table 1. Evolution of dry body weight, blood urea, serum creatinine and peritoneal urea clearance and ultrafiltration
Months 0 6 12 18 24 30 36 42 48 54 60
Dry body weight kg 58.2
2.79
62.3
2,50
64 66.2 68.4 69.3 68.4
2.29 2.50 2.53 2.79 2.79
69.1
2.63
69.1
3.0
70
3.41
70.6
3.33
Ureamg/d! 172 111 118 131 129 123 119 120 119 129 114
Creatinine mg/di 10.8
0.57
9.7
0.61
9.8 10.1 10.3 10.4 10.2
0.73 0.67 0.72 0.68 0.67
10.3
0.69
10.6
0.68
10.6
0.71
10.4
0.75
Peritoneal urea 6.70 7.01 6.81 6.54 6.90 6.88 6.75 7.12 6.51 6.50 6.50
clearance mi/mm 2.19 1.34 1.18 1.17 1.08 1.18 1.25 1.09 1.15 1.12 1.04
Net peritoneal UF 1.270 1.790 1.532 1.070 1.550 1.513 1.380 1.980 990 1.100 1.020
mi/day 85 65 115 96 86 52 95 115 96 88 64
Table 2. Calculation of urea distribution volume (liters)
Months Start 6 12 18 24 30 36 42 48 54 60
Method 1
% of body wt(N 4) 41.6 43.4 44.3 44.8 46.4 46.5 46.4 46.4 46.7 46.4 46.9
9 (N 12) 29.9 32.4 33.4 34.9 36 36.6 36.0 36.5 36.4 37.2 37.4
Overall (N = 16) 32.9
1.58
35.2
1.63
36.1 37.4 38.6 39.1 38.6 39.0
1.68 1.65 1.69 1.71 1.85 1.95
39.4
2.03
39.6
1.98
39.9
1.96
Method 2
Watson formulae(N = 4)
9 (N = 12)
Overall (N = 16)
39.6
29
31.6
1.45
406
29.4
32.2a
1.42
41.0 41.3 42.1 42.2 42.0 42.0
30.5 30.5 31.7 31.8 31.7 31.9
331b 332b 343b 344b 344b 344b
1.51 1.49 1.61 1.73 1.59 1.35
42;0
31.9
344b
1.38
42.1
32.2
347b
1.35
42.0
32.4
348b
1.36
a p < 0.05, method I vs. IIbp< 0.01, method! vs.!!
From a pre-CAPD value of 172 15 mg/dl, the subsequent
blood urea values fluctuated in a relatively narrow range
between 111 8 mgldl and 131 13 mg/dl. All mean blood urea
values during CAPD were significantly lower than the mean
pre-CAPD value (P < 0.001).
Serum creatinine values did not substantially change over the
five years. The results also show that over this five-year study
period, the peritoneal urea clearing and ultrafiltrating capacity
remained stable in these patients.
Major changes occurred in clinical dry body weight. A rapid
rise from 58.2 2.79 kg, achieved two to three weeks after
training, to relatively stable values between 24 and 30 months
(68.4 2.53 and 69.3 2.79 kg) occurred (P < 0.01). The
changes in mean body weight between 24 and 48 months were
not significant (P > 0.05). There was a further slight increase at
60 months. The difference between the body weight at 24
months (68.4 2.53 kg) and 60 months (70.6 3.33 kg) was
significant (P < 0.05). These changes in body weight, and
therefore in calculated urea distribution volumes, are a first
important factor influencing the KTIV urea index in CAPD.
There are, however, important differences between the meth-
ods used to calculate the distribution volume.
Table 2 compares the distribution volumes calculated either
as a fixed percent of body weight (method I) or by the Watson
formulae (method II). It should be noted that the absolute
values for urea distribution volumes are strikingly different with
the two methods, with method I systematically giving higher
values than method II.
Consequently, the effect of the increase in calculated urea
distribution volume on the evolution of KT/V urea index shall
be less pronounced with the Watson method than with the first
method. It should, however, be noted that with both methods
an evolution in the same direction in urea distribution volume is
observed (an increase with 21% and 10% after 5 years, with the
first and second methods, respectively).
The evolution of the mean values for the normalized total
KT/V urea index calculated with the distribution volumes
according to the two methods is given in Table 3.
The percent contribution of the normalized residual renal
urea index to the total normalized urea index is indicated
between brackets. There is a progressive decline in the total
KT/V urea index with time, irrespective of the methods of
calculating the distribution volume. In view of this parallelism
and to allow a better comparison with the two previously
published papers on this subject [5, 6], only the KT/V urea
index, based on the calculation of the urea distribution volume
as a percent of body weight (method I), will further be dis-
cussed.
The mean total index determined after stabilization on CAPD
is 0.96 0.06. At this time, the contribution of the urinary
KT/V urea index is 0.275 0.06 or 28.6%. At 12 months, the
mean KT/V urea index of 0.83 0.09 is significantly lower than
at the start (P < 0.0!). A further gradual decrease to a value of
0.55 0.05 is noted at five years. At this end point of follow-up,
the urinary KT/V urea index has fallen to zero, since after four
years of CAPD, all patients except one were in complete anuria.
The last meaningful contribution of residual renal function
(13%) to the total KT/V urea index was at 36 months of CAPD.
For calculation of the PCR values, 12 patients showed a stable
body weight between 24 and 48 months of CAPD treatment.
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Table 3. Evolution of the total and residual renal KT/V urea index
Months 0 6 12 18 24 30 36 42 48 54 60
Total KT/V 0.96 0.90 0.83 0.75 0.73 0.70 0.68 0.65 0.60 0.62 0.55
Ureaa 0.06 0.06 0.05 0.04 0.04 0.04 0.05 0.03 0.04 0.05 0.05
Renal KT/V 0.275 0.23 0.19 0.16 0.13 0.11 0.09 0.03 0.05 0.06 0
Ureaa
Total KT/V
0.06
(26.6%)
1.00
0.06
(25.5%)
0,95
0.06
(22.9%)
0.90
0.04
(21%)
0.86
0.05
(18%)
0.82
0.05
(15.7%)
0.77
0.03
(13.2%)
0.75
—
(4.6%)
0.73
—
(8.3%)
0.69
—
(9.7%)
0.70
—
—
0.63
Urea1' 0.06 0.05 0.06 0.05 0.05 0.06 0.07 0.06 0.04 0.05 0.04
Renal KT/V 0.286 0.25 0.21 0.18 0.145 0.125 0.10 0.034 0.057 0.07 0
Ureab 0.06
(28.6%)
0,05
(26.3%)
0.05
(23.3%)
0.04
(21%)
0.04
(17.7%)
0.04
(16%)
0.03
(13.3%)
-
(4.65%) (8.3%) (10%)
Ia Index calculated according to methodb Index calculated according to method II
During this interval, the mean plasma albumin levels in these
12 patients varied between 3.93 0.61 gIdl and 3.78 0.59 g/dl
(P < 0.05). At 24 months, a PCR value corrected for protein
loss in the dialysate of 65.91 5.61 g/day was obtained,
corresponding with a protein catabolic rate of 0.98 0.05 g/kg
day. Over this two year interval, these values decreased slightly
to a mean of 0.87 0.05 g/kg at four years (P < 0.05). Only four
out of the 12 patients maintained a PCR and therefore a daily
protein intake of more than 1 g/kg body weight during this
period. The mean daily protein loss in the dialysate in these 12
patients was 9.56 0.87 g at 24 months and 9.66 0.74 at 48
months.
For the calculation of a correlation between PCR and KTIV
urea index, a total number of 58 simultaneous determinations of
both parameters were available. A significantly positive corre-
lation between these two parameters was found (r =0.56, P <
0.001) (y = 0.37 + 0.77 x).
No significant correlations were found between KT/V urea
index and a number of hematological and biochemical param-
eters, such as hemoglobin, hematocrit, plasma albumin, or
parathormone levels. In contrast, between the individual KT/V
urea indices over five years and the individual nerve conduc-
tivity data, a significant positive correlation was found (r
0,29; P < 0.05) (y = 0.62 + 5.77 x).
Figure 1 depicts the evolution of the means of nerve conduc-
tivity values over the years of treatment in two arbitrarily
divided groups of patients: a first group of five patients (full line)
who during the first year of CAPD showed a mean KT/V urea
lower than 0.8, and nine other patients (broken line) who had a
first year KT/V urea of higher than 0.8. In the second group,
data from one patient suffering from a traumatic paraplegia
several years before start of CAPD were excluded. In the first
group, one patient with an initial nerve conductivity of 26
rn/sec. but where further data could not be obtained, was not
included in this analysis. As can be noted, the patients with a
low KT/V urea developed a deterioration of the nerve conduc-
tivity during the follow-up; on the other hand, the second group
maintained normal nerve conductivity. Despite the low number
of patients in both groups, the differences were highly signifi-
cant from the third year on.
Since there was no patient or technique drop out, one other
morbidity parameter that was considered for correlation with
the mean KT/V urea index/year was the number of hospitaliza-
tion days/year, training days not included. As can be noted from
Figure 2, a significant negative correlation between both param-
eters was observed (r =
—0.46; P < 0,001). As KT/V urea also
decreased over time, we excluded the time factor, by correlat-
ing the mean KT/V urea index over the total five year period to
the mean hospitalization rate per year (not shown). A highly
significant negative correlation between both parameters was
found (r =
—0.68; P < 0.001).
For analysis of relation between the KT/V urea index and the
peritonitis rate, the KT/V urea values were averaged over the
five years of CAPD in the 16 patients and the number of
peritonitis episodes was calculated. As can be noted from Table
4A, eight patients showed an average five-year KT/V urea index
higher than 0.8 (mean 5 years KT/V urea was 0.84; range 0.80 to
C.)
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E
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C0
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43
40
37
34
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28
25
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Follow-up, years
Fig. 1. Evolution of the mean values of peripheral nerve conductivity
over 5 years. Symbols are: (S •) results in 5 patients with a first
year KT/V urea index < 0.8; (A----A) results in 9 patients with a first
year KT/V urea index > 0.8; * < 0.05 between the 2 groups; <
0.01 between the 2 groups.
0.26
6], our approach thus allows an analysis of the factors deter-
0 mining the "natural" evolution of this parameter.
I I I I I I The decline in KT/V urea index is the result of two opposing
0 20 40 60 80 100 changes, not directly related to the peritoneal clearing capacity.
The first factor is the gradual decrease in residual renal function
Hospitalization days and therefore urinary urea clearance. We believe this to be the
Fig. 2. Plot of number of hospitalization days/year against Kr/V major contributor for the decline in overall KT/V urea index in
values/year, 80 studies in 16 patients. r = —0.46; P < 0.001. CAPD. In the first two years of CAPD, endogenous renal urea
clearance contributed 20% or more to the overall KT/V urea
index. After five years of CAPD, the renal contribution had
0.95). The total number of peritonitis episodes in this group was fallen to zero, since all patients showed complete anuria. It is
nine, which gives an incidence of one per 53.3 patient months, interesting to note that in the cross sectional study by Lysaght
The other eight patients had an average five-year KT/V urea et al [4], the renal contribution to the overall KT/V urea index
index lower than 0.8 (mean 0.62; range 0.55 to 0.71). The total was 18% after a mean of 26 3.2 months of CAPD treatment.
number of peritonitis episodes in this group was 34, giving an The second factor leading to the decrease in overall KT/V
incidence of one per 14.1 patients months (P < 0.001). As could urea index is the increase of body weight with time, and hence
be expected, a significant, although weaker, negative correla- in calculated urea distribution volume. We considered the
tion was found between KT/V urea index and number of volume of distribution for urea to be 0.55 x body weight for
hospitalization days for peritonitis only (r = 0.27; P < 0.05). women and 0.60 X body weight for men, the same formula used
In addition, we further analyzed the data on hospitalization by Blake et al [6]. In contrast with hemodialysis patients where
days and peritonitis rate in relation to the KT/V urea index the mathematical analysis of the blood urea profile allows a
observed during the first year of CAPD. This would allow us to calculation of the urea distribution volume, the constant blood
see if this initial KT/V urea index has any correlation with later urea levels in CAPD patients make the distribution volume not
morbidity. exactly calculable. Numerous studies assumed that the urea
As can be noted from Table 4B, the six patients who during space closely equates the total body water content [10—13].
their first year had a mean KT/V urea index below 0.8 not only Studies using isotope tracers of urea in both acutely uremic
had a significantly higher peritonitis rate with a higher number dogs [14] and patients on hemodialysis [15] have found that the
of hospitalization days, but more importantly, they also needed urea distribution space may be different from the total water
more and longer hospitalizations for other morbid events than space by approximately 12 to 14%. Matthews and Downey [16]
peritonitis, have shown that the plasma disappearance curve of urea in
normal individuals is more compatible with a two pool, than
Discussion with a single pool model. However, the two pools together
The major finding of this study is the continuous decline in correspond very closely with the total body water compart-
overall KT/V urea index over a five year follow-up in clinically
stable CAPD patients. This result is, in view of the study
design, not influenced by external factors interfering with the
evolution of this parameter, such as patient or technique drop
out or, more importantly, adaptations in the daily dose of the
dialysis. In contrast with the few earlier studies in this field [5,
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1.6
1.33 :
.
A.
Table 4. Peritonitis incidence according to KT/V urea index
w
1.06
0.8
0.53
B.
0•
Overall 5 year KT/V urea index >0.80 <0.80
N 8 8
Total N peritonitis 9 34
Incidence/pt month 1/53.3 1/14.12"
N of patients without peritonitis 4/8 1/8
Initial KT/V urea index (first year) >0.80 <0.80
N 10 6
Total N peritonitis over 5 years 15 28
Incidence/pt month 1/40 1/12.8k
N of patients without peritonitis 4/10 1/6
Hospitalization days
Total over 5 years (percent of 473 (2.6%) 690 (6.3%)
total treatment days)
For peritonitis (percent of total 127 (0.7%) 216 (2.0%)
treatment days)
For other causes (percent of 346 (1.9%) 474 (4.3%)
total treatment days)
P < 0.05; b p < 0.001
ment.
It can be argued that the spectacular increase in clinically-
apparent dry body weight in CAPD patients is not necessarily
associated with a parallel increase in total body water. The
continuing caloric loading from the glucose dialysate leads to
obesity in many CAPD patients. We believe, therefore, that
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accepting total body water as a constant fraction of total body
weight in these patients introduces errors in the calculation of
the KT/V urea index. In any case, the calculated index will be
artificially lowered during the evolution. This is illustrated by
our data calculated with the Watson formulae (Table 2). In
these formulae, other parameters such as height and age,
besides body weight are included. Using this calculation
method, markedly higher KT/V urea values are obtained, but
the evolution with time is similar. It should be added here that
the anthropometric data obtained by Watson et al [7] are
derived from measurements in individuals with normal renal
function.
The present results confirm the recent data by Blake et al [61
where within three years of CAPD treatment, a progressive fall
in the KT/V urea index was observed. In their study, this
decline was due to mainly to a gradual decrease in residual renal
function, and to a lesser extent to an increase in body weight.
To better evaluate the long-term clearing capacity of the
peritoneum for small molecules such as urea and creatinine, the
results of Table 1 may be of interest. It appears that, in this
selected population group, the peritoneal clearing capacity at
least for urea as well as the ultrafiltration capacity is well
preserved over five years. The clearances were calculated by
measuring the urea excretion by the drained dialysate over 24
hours. These results confirm the longitudinal study of PET tests
in 49 CAPD patients for up to 30 months by Blake et al [17] and
the results of a cross sectional study of peritoneal clearances in
patients on CAPD for 0.6 to 52 months by Park et al [18]. Both
studies found also stable peritoneal clearances.
To better evaluate the prognostic value of the KT/V urea
index, the recently published study of Blake et al [6] is some-
what disappointing since these authors could not establish any
correlation between the KT/V urea index and clinical outcome
parameters such as death, technical failure, hospitalization days
and a number of subjective complaints. Their results may be
biassed by the high drop-out rates during the course of their
study, and are in contrast not only with the results of the
present study, but also with the data published by Teehan et al
[5]. These authors found a negative correlation between the
number of hospitalization days and the KT/V urea index. In
addition, the peritonitis incidence in our population was signif-
icantly lower in the subgroup of eight patients with an overall
KT/V urea index higher than 0.8, compared to the other eight
patients with a low KT/V urea index. The question of a causal
relationship between KT/V urea index and peritonitis remains
open. Furthermore, the same relation between KT/V urea index
and peritonitis rate was maintained when we restricted the
analysis to the average KT/V urea index during the first year of
treatment. This means that a KTIV urea index, calculated with
a urea distribution volume as a constant percent of body weight,
which is below 0.8 during the first year of CAPD could have
some predictive value for the later development of peritonitis.
Moreover, a similar relation could be established between this
first-year KT/V index and the evolution of the peripheral nerve
conductivity. We want to emphasize that these results have
been obtained in a limited number of patients and in a retro-
spective way. However, if confirmed by future prospective
studies in a larger patient group, the KT/V urea index could
become an important and easy clinical parameter for adequacy
of dialysis in CAPD. A significant correlation between PCR and
KTIV urea index was also established. This is in agreement with
previous studies, where a positive correlation between these
two parameters in both hemodialysis [19] and peritoneal dialy-
sis [4, 6] is found. We restricted the calculation of PCR to a
period of 24 months during which the patients showed a stable
dry body weight and therefore were assumed to be in a steady
metabolic state. If body weight is allowed to fluctuate, a change
in this parameter can affect PCR without changes in protein
catabolism or intake. Blake et al [61 did not apply such a
restriction.
A mean PCR of almost 1 g/kglday was in our patients
achieved at two years of CAPD, and thereafter the value
dropped significantly to 0.87 0.05 after four years of therapy.
In addition, the serum albumin levels in these patients were well
maintained in the (lower) normal range. This reflects a very
acceptable protein status.
We want to stress that the studied patient population con-
sisted of non-diabetic and long-term CAPD survivors. The
values we obtained for KT/V urea and PCR are rather high
compared to those in other studies. This may partly be due to
the presence of mainly females with a rather low initial body
weight. It is thus possible that our patients are not entirely
representative of the CAPD population as a whole.
Nevertheless, the present observations indicate: (1) that at
least in a subgroup of patients who were treated chronically
with a constant daily dose of CAPD, the decline in KT!V urea
index is the consequence of the fall in residual renal function,
and is not due to a failure of the clearing capacity of the
peritoneal membrane. (2) A second important parameter influ-
encing in a negative way the KT/V urea is the rise in dry body
weight, affecting the calculation of the urea distribution volume.
(3) There is a correlation between the KT/V urea index and
some clinical variables like total number of hospitalization
days, peritonitis rate and peripheral nerve conductivity.
Acknowledgments
The authors thank the patients and nursing staff of the Division of
Nephrology for their cooperation. The secretarial work of Mrs. Lucrèce
De Torck, Chantal Bergen, Ingrid Verslycken, and Mr. Marc Gillis is
highly appreciated.
Reprint requests to Norbert H. Lameire, M.D., Renal Division,
University Hospital, 185, Dc Pintelaan, B-9000 Gent, Belgium.
References
I. KESHAvIAH PK, COLLINS A: A re-appraisal of the National Coop-
erative Dialysis Study. (abstract) Kidney mt 33:227,1988
2. LUNDIN AP: What's wrong with the American way of ESRD
treatment? Semin Dial 4:77—79, 1991
3. PARKER TF: What's wrong with the American way of ESRD
treatment? Semi,, Dial 4:81—82, 1991
4. LYSAGI-IT MJ, POLLOCK CA, HALLET MD, IBE5L LS, FARRELL PC:
The relevance of urea kinetic modeling to CAPD. Trans Am Soc
Art if Intern Organs 35:784—790, 1989
5. TEEHAN BP, SCHLEIFER CR, BROWN JM, SIGLER CR, RAIMONDO
J: Urea Kinetic analysis and clinical outcome on CAPD. A five year
longitudinal study. Adv Pent Dial 6:181—185, 1990
6. BLAKE PG. SOMBOLOS K, ABRAHAM G, WEISSGARTEN J, PEMBER-
TON R, CHU GL, OREoPouLos DO: Lack of correlation between
urea kinetic indices and clinical outcomes in CAPD patients.
Kidney mt 39:700—706, 1991
432 Lameire et a!: Urea kinetics in CAPD
7. WATSON PE, WATSON ID, BATT RD: Total body water volumes for
adult males and females estimated from simple anthropometric
measurements. Am J Gun Nutr 33:27—39, 1980
8. BORAH MF, SCHOENFELD PY, GOTCH FA, SARGENT JA, WOLF-
SON M, HYMPHREYS MH: Nitrogen balance during intermittent
dialysis therapy of uremia. Kidney mt 14:491—500, 1978
9. RANDERSON DH, CHAPMAN GV, FARRELL PC: Amino acid and
dietary status in CAPD patients in Peritoneal Dialysis, edited by
ATKINS RC, FARRELL PC, THOMSON N, Edingburgh, Churchill-
Livingstone, 1981, pp 180—191
10. STEFENSON KA: Some determination of the total body water in
man by means of intravenous injections of urea. Acta Physiol
Scand 13:282—290, 1947
11. SAN PIETRO A, RITTENBERG D: A study of the rate of protein
synthesis in humans: I. Measurement of the urea pooi and urea
space. J Biol Chem 20:445—473, 1953
12. WALSER M, BODENLOS U: Urea metabolism in man. J Clin Invest
38:1617—1626, 1959
13. ScHOLz A: Investigation on distribution and turnover rate of
'4C-urea and tritiated water in renal disease. Proc Eur Dial Trans-
plant Assoc 4:240—244, 1967
14. KESHAVIAH P, ILSTRUP K, SHAPIRO W, HANSON 0: Hemodialysis
urea kinetics is not a single pool. (abstract) Am Soc Nephrol 67A,
1984
15. ILSTRUP K, HANSON G, SHAPIRO W, KESHAVIAH P: Examining the
foundations of urea kinetics. Trans Am Soc Artf Intern Organs
31:164—167, 1985
16. MATTHEWS DE, DOWNEY RS: Measurement of urea kinetics in
humans: A validation of stable isotope tracer methods. Am J
Physiol 246 (Endocrinol Metab 9):E519—E527, 1984
17. BLAKE PG, ABRAHAM 0, SOMBOLOS K, IZATT S, WEISSGARTEN J,
AYIOMAMITIS A, OREOPOULOS DO: Changes in peritoneal mem-
brane transport rates in patients on longterm CAPD. Adv Pent Dial
5:3—7, 1989
18. PARK MS, LEE J, LEE MS, BAICK SH, HWANG SD, LEE HB:
Peritoneal solute clearances after four years of continuous ambu-
latory peritoneal dialysis (CAPD). Pent Dial mt 9:75—78, 1989
